Oncolytics Biotech Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to pelareorep in combination with Roche's anti-PD-L1...
Biological Dynamics, a company developing its exosome-isolation ExoVerita platform for early disease diagnostics, announced it has received IRB approval and will soon begin to...
Armis, the leading asset visibility and security company, announced that it has been named a clear leader for technology excellence and customer impact by...
Journey Biosciences, Inc., a biotechnology company offering biomarker-based predictive risk screening technologies for diabetes-related complications, announced the launch of its flagship product NaviDKD.
NaviDKD, a...
